HCG: Dosage, Benefits & Side Effects
Also known as: Human Chorionic Gonadotropin, hCG, Novarel, Pregnyl
By Peptide Assistant Editorial Team · · · 11 sources cited
HCG is a prescription drug. It is FDA-approved for specific conditions in men, boys and women. It is not approved for weight loss, and its label says it has not been shown to help with it. Using it alongside testosterone therapy is off-label and a prescriber's decision. Peptide Assistant does not sell HCG or any other product.
Overview
HCG (human chorionic gonadotropin) is a hormone made by the placenta during pregnancy, and the hormone a pregnancy test detects. It is a glycoprotein built from two peptide chains, 237 amino acids in all. Prescription HCG is purified from the urine of pregnant women and sold as Novarel, Pregnyl and generics. In men it acts like luteinizing hormone (LH), the pituitary signal that tells the testes to make testosterone. It is FDA-approved for hypogonadotropic hypogonadism in males, for undescended testicles in boys, and to trigger ovulation in women having fertility treatment. It is not approved for weight loss.
Mechanism of Action
HCG binds the same receptor as luteinizing hormone on the Leydig cells of the testes. The FDA label describes its action as "virtually identical to that of pituitary LH": it stimulates those cells to produce androgens, mainly testosterone. Testosterone made inside the testes reaches concentrations far above blood levels, and sperm production depends on it. This is why HCG comes up with testosterone therapy. Testosterone taken from outside tells the pituitary to stop sending LH and FSH. Without LH the testes make little testosterone of their own, they shrink, and sperm production can fall to zero. HCG stands in for the missing LH signal, so the testes keep working while blood testosterone comes from the prescription. HCG stays in the blood much longer than LH does, which is why it is injected a few times a week. In women, the same LH-like action triggers ovulation after the follicles have been prepared with other fertility drugs.
HCG Benefits: What the Research Shows
- Coviello and colleagues (Journal of Clinical Endocrinology & Metabolism, 2005) gave healthy men testosterone enanthate plus HCG at 125, 250 or 500 IU every other day for three weeks. Testosterone inside the testes ended 25% below baseline at 125 IU, 7% below at 250 IU and 26% above at 500 IU. The authors concluded that relatively low-dose HCG keeps intratesticular testosterone in the normal range.
- Hsieh and colleagues (Journal of Urology, 2013) reviewed 26 men on testosterone therapy who also took 500 IU of HCG every other day. None became azoospermic, semen measures did not change over more than a year of follow-up, and nine of the men's partners became pregnant. The study was small and retrospective, with no control group.
- The American Urological Association's testosterone deficiency guideline (2018) states that testosterone should not be prescribed to men who are currently trying to conceive. HCG is one of the alternatives it discusses for men who want to keep their fertility, and it is the only one of them that is FDA-approved for use in males.
- HCG alone can raise testosterone in men whose testes work but whose pituitary signal is missing. That is the labeled use: selected cases of hypogonadotropic hypogonadism.
- Weight loss: the FDA label states that HCG "has not been demonstrated to be effective adjunctive therapy in the treatment of obesity", that there is no substantial evidence it increases weight loss beyond calorie restriction, and that it has no known effect on fat mobilization, appetite or hunger. FDA has said that over-the-counter HCG diet products are illegal.
HCG Dosage
- FDA label, hypogonadotropic hypogonadism in males: 500 to 1,000 USP units three times a week for three weeks, then the same dose twice a week for three weeks.
- FDA label, alternative regimen for the same condition: 4,000 USP units three times a week for six to nine months, then 2,000 units three times a week for three more months.
- The label says the regimen depends on the indication, the patient's age and weight, and the physician's preference.
- Alongside testosterone therapy (off-label): the published studies used 125 to 500 IU every other day. Prescribers commonly use 250 to 500 IU two or three times a week.
- Route: the label is for intramuscular injection only. The lower doses used alongside testosterone are often prescribed as subcutaneous injections, which is off-label.
- Mixing: the label reconstitutes a 10,000-unit vial with 10 mL of the supplied bacteriostatic water, which gives 1,000 units per mL. IU are not the same as the units on an insulin syringe; the HCG dosage calculator converts one to the other.
- Undescended testicles in boys and ovulation induction in women have their own label regimens, set by a specialist. They are not covered here.
Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.
HCG Side Effects & Safety
Known Side Effects
- Headache, irritability, restlessness, depression and fatigue (all listed on the label).
- Edema (fluid retention), from the rise in androgens.
- Gynecomastia (growth of breast tissue in men).
- Pain at the injection site.
- Allergic reactions, including anaphylaxis, have been reported with HCG made from urine.
- Precocious puberty in boys treated for undescended testicles. The label says to stop treatment if signs appear.
- In women having fertility treatment: ovarian hyperstimulation, ruptured ovarian cysts, multiple births and blood clots.
Safety Profile
HCG is a prescription drug with decades of use, and the risks on its label come mostly from the hormones it raises. The label lists three contraindications: precocious puberty, prostate cancer or another androgen-dependent tumor, and a previous allergic reaction to HCG. Because androgens can cause fluid retention, it calls for caution in people with heart or kidney disease, epilepsy, migraine or asthma. HCG raises testosterone and, through it, estradiol, so prescribers who use it with testosterone therapy usually follow both by blood test. An HCG injection will also turn a pregnancy test positive, in anyone. HCG is on the World Anti-Doping Agency's prohibited list for male athletes. Since March 23, 2020, FDA has regulated HCG as a biologic, and US compounding pharmacies lost the exemptions that had let them compound it. FDA-approved products remain available by prescription. Vials sold online without a prescription are unregulated, and their identity, strength and sterility are unverified.
What to Expect
The labeled course for hypogonadotropic hypogonadism lasts six weeks at the lower dose, or up to a year at the higher one, with testosterone checked along the way. Alongside testosterone therapy, the effect on the testes shows up within weeks: in the Coviello study, intratesticular testosterone was measured after three weeks of treatment. Sperm production is slower. A full cycle takes roughly two to three months, so semen analyses are repeated over months, and the Hsieh study followed men for more than a year. What HCG does for an individual depends on why testosterone is low in the first place. It can only stimulate testes that are able to respond.
Storage & Handling
Store unmixed vials at room temperature, 68–77°F (20–25°C). After mixing with the supplied bacteriostatic water, refrigerate at 36–46°F (2–8°C) and do not freeze. Use a mixed vial within 60 days per the Pregnyl and Fresenius Kabi generic labels, or within 30 days per the Novarel label. Go by the label of the product you have.
References
- CHORIONIC GONADOTROPIN for injection, USP: full prescribing information. Fresenius Kabi USA, LLC, via DailyMed. 2025.
- NOVAREL (chorionic gonadotropin for injection, USP) label. Ferring Pharmaceuticals Inc., via DailyMed. 2025.
- Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005.
- Hsieh TC, Pastuszak AW, Hwang K, et al. Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol. 2013.
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018.
- Hochu G, Geyer-Kim I, Kim E. Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies. Transl Androl Urol. 2025.
- Krzastek SC, Smith RP. Non-testosterone management of male hypogonadism: an examination of the existing literature. Transl Androl Urol. 2020.
- Questions and Answers on HCG Products for Weight Loss. U.S. Food and Drug Administration. 2016.
- Notice to Compounders: Changes that affect compounding as of March 23, 2020. U.S. Food and Drug Administration. 2020.
- The Prohibited List 2026, section S2.2.1 Testosterone-stimulating peptides in males. World Anti-Doping Agency. 2026.
- PREGNYL (chorionic gonadotropin) for injection label. Organon LLC, via DailyMed. 2025.
Related Peptides
Track HCG in Your Protocol
Log your HCG doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.
Start Tracking Free